Know What We Do

Lotus Labs has extensive experience in conducting Clinical Trials in healthy volunteers, patient populations and special populations. With the nerve centre at Bangalore, India, Lotus Labs offers an extensive portfolio of services – spanning Phase I to III studies – for global pharmaceutical and biotechnology companies. With a battery of services, from end-to-end Clinical Trials to stand alone services, Lotus Labs has an impressive track record with expertise across all facets of Clinical Research, powered by proficiency in the areas of Bio Studies, Clinical Trials, Bioanalytical Research, Biometrics, Medical Writing and Regulatory Services.

Leadership in the realm of early to late phase Clinical Development, proven expertise across a broad range of therapeutic areas, a collaborative approach to partnerships both at home and abroad – have ensured that Lotus Labs is today the preferred hub of Clinical Research for Indian & International sponsors.

Lotus Labs offers a service portfolio that is truly comprehensive consisting of a range of early and late development studies and one that is characterized by high levels of quality and reliability – powered by experienced professionals and cutting edge technology.

  • Lotus Labs is a client focused and systems driven organization that is committed to provide best-in-class solutions and services Our research professionals and support staff are highly qualified and well experienced to ensure successful project delivery with the assurance of quality and reliability at all times
  • Lotus Labs has developed robust systems and procedures to guarantee process standardization and adhere to globally recognized guidelines
  • Over 2,600 studies completed
  • Over 500 methods developed
  • Over 86 Regulatory inspections
  • 2 Clinical Facilities in India
  • Bio Studies (BA / BE)
  • Phase-I to phase-IV studies
  • Range of clinical pharmacology studies including:
    • Food Effect
    • Proof of Concept
    • Drug Interaction Studies
    • Food effect Studies
    • Pharmacokinetic / Pharmacodynamic Studies
    • Biosimilars
    • Exploratory Studies
      • Micro dosing
      • Biomarkers
    • Special Population Studies
      • Geriatric Patients
      • Renal Impairment
      • Hepatic Impairment
      • Slow / fast metabolizers
      • Asthmatics / COPD
      • Subjects with Diabetes / Hypertension / Hyperlipidemia / CV risk factors
      • Psoriasis / Schizophrenia
  • Supplementary Services